SCHEMBL28260600

SCHEMBL28260600

CCOc1ccc(Cl)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.50
GPR84 Q9NQS5 1/20 0.46
KMT2A Q03164 2/20 0.44
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
KDM4E B2RXH2 3/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 2/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
TAS1R3 Q7RTX0 2/20 0.41
TAS1R1 Q7RTX1 2/20 0.41
HPGD P15428 2/20 0.41
ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24262858 0.85 GPR84 (0.50) GPR84KMT2AKDM4ETSHRNPC1
SCHEMBL3750536 0.84 NQO1 (0.50) NQO1KMT2AFFAR1FFAR4KDM4E
SCHEMBL1632709 0.83 SMN1; SMN2 (0.47) NQO1KMT2AKDM4EMEN1HPGD
SCHEMBL9425356 0.81 NQO1 (0.56) NQO1KMT2AKDM4ETSHRTDP1
SCHEMBL1548013 0.81 KDM4E (0.58) NQO1KMT2AFFAR1FFAR4KDM4E
SCHEMBL30905970 0.79 CA12 (0.46) GPR84KMT2AKDM4ETSHRTDP1
SCHEMBL322093 0.79 CA12 (0.46) GPR84KMT2AKDM4ETSHRTDP1
SCHEMBL13425464 0.78 ALDH1A1 (0.49) NQO1GPR84KMT2AFFAR1KDM4E
SCHEMBL30753685 0.78 NQO1 (0.52) NQO1KMT2AKDM4ETSHRTDP1
SCHEMBL15057334 0.78 NQO1 (0.52) NQO1KMT2AKDM4ETSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106986867-B Heterocycle amine as PI3K inhibitor 因塞特控股公司 2019-06-28 CN disclosed
CN-109010343-A The purposes of Pyrazolopyrimidine derivative treatment PI3K δ associated disease 因赛特公司 2018-12-18 CN disclosed